To access the full text documents, please follow this link: http://hdl.handle.net/2445/112024
dc.contributor | Universitat de Barcelona |
---|---|
dc.contributor.author | Yigit, Burcu |
dc.contributor.author | Halibozek, Peter J. |
dc.contributor.author | Chen, Shih-Shih |
dc.contributor.author | O'Keeffe, Michael S. |
dc.contributor.author | Arnason, Jon |
dc.contributor.author | Avigan, David |
dc.contributor.author | Gattei, Valter |
dc.contributor.author | Chiorazzi, Nicholas |
dc.contributor.author | Wang, Ninghai |
dc.contributor.author | Engel Rocamora, Pablo |
dc.contributor.author | Terhorst, Cox |
dc.date | 2017-06-06T14:07:16Z |
dc.date | 2017-06-06T14:07:16Z |
dc.date | 2016-03-25 |
dc.date | 2017-06-06T14:07:17Z |
dc.identifier.citation | 1949-2553 |
dc.identifier.citation | 667633 |
dc.identifier.uri | http://hdl.handle.net/2445/112024 |
dc.format | 15 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Impact Journals |
dc.relation | Reproducció del document publicat a: https://doi.org/10.18632/oncotarget.8378 |
dc.relation | Oncotarget, 2016, vol. 7, p. 26346-26360 |
dc.relation | https://doi.org/10.18632/oncotarget.8378 |
dc.rights | cc-by (c) Yigit, Burcu et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/3.0/es |
dc.subject | Leucèmia limfocítica crònica |
dc.subject | Limfomes |
dc.subject | Medicaments |
dc.subject | Chronic lymphocytic leukemia |
dc.subject | Lymphomas |
dc.subject | Drugs |
dc.title | A combination of an anti-SLAMF6 antibody and ibrutinib efficiently abrogates expansion of chronic lymphocytic leukemia cells |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |